Blog

Here we provide our perspectives on industry trends, regulations and challenges facing patients, payors, providers and other stakeholders in the health care industry.

Biosimilars - A Bane or a Blessing

Last week the US Senate held a hearing to discuss the rising cost of insulin; the prices of insulin have trebled in the last few years and one of the factors that were reported was the need for more